Latest News and Press Releases

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28%...

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that it is now offering Foundayo™ (orforglipron) to...

MONTREAL and CHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of...

CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "US FDA - Understanding Key Factors When Working with the FDA (May 12, 2026)" training has been added to ResearchAndMarkets.com's offering.This course...

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "New EU GMP Annex 1: Compliant Sterile Medicinal Products (May 19th - May 23rd, 2026)" training has been added to ResearchAndMarkets.com's...

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "Navigating Regulatory Compliance Whilst Developing and Distributing Polymerase Chain Reaction (PCR)-Based IVD Tests (May 15, 2026)" training has been...

ACV gummy label analysis: what ingredient panels disclose, where research-supported dosages diverge from proprietary blends, and what to check

Vita Smart Cup Massager claims examined. 2026 report covers suction, red light, and heat features, undisclosed specs, pricing, and return terms.

Investors who lost money in AARD after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug...

ZUG, Switzerland, April 07, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing...